Silvercrest Asset Management’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$695K Buy
8,887
+161
+2% +$12.6K ﹤0.01% 672
2025
Q1
$632K Buy
8,726
+57
+0.7% +$4.13K ﹤0.01% 659
2024
Q4
$642K Sell
8,669
-147
-2% -$10.9K ﹤0.01% 654
2024
Q3
$582K Buy
8,816
+147
+2% +$9.7K ﹤0.01% 633
2024
Q2
$801K Sell
8,669
-1,687
-16% -$156K 0.01% 645
2024
Q1
$990K Sell
10,356
-16
-0.2% -$1.53K 0.01% 615
2023
Q4
$791K Sell
10,372
-379
-4% -$28.9K 0.01% 616
2023
Q3
$745K Hold
10,751
0.01% 634
2023
Q2
$1.01M Sell
10,751
-3,242
-23% -$306K 0.01% 593
2023
Q1
$1.16M Sell
13,993
-18,389
-57% -$1.52M 0.01% 557
2022
Q4
$2.42M Buy
32,382
+45
+0.1% +$3.36K 0.02% 444
2022
Q3
$2.67M Buy
32,337
+7,527
+30% +$622K 0.02% 412
2022
Q2
$2.36M Buy
24,810
+10,726
+76% +$1.02M 0.02% 444
2022
Q1
$1.66M Sell
14,084
-13
-0.1% -$1.53K 0.01% 529
2021
Q4
$1.83M Buy
14,097
+750
+6% +$97.2K 0.01% 498
2021
Q3
$1.51M Sell
13,347
-11,897
-47% -$1.35M 0.01% 520
2021
Q2
$2.62M Sell
25,244
-2,568
-9% -$266K 0.02% 463
2021
Q1
$2.33M Buy
27,812
+17,908
+181% +$1.5M 0.02% 471
2020
Q4
$903K Sell
9,904
-146
-1% -$13.3K 0.01% 547
2020
Q3
$802K Hold
10,050
0.01% 537
2020
Q2
$695K Hold
10,050
0.01% 558
2020
Q1
$632K Sell
10,050
-120
-1% -$7.55K 0.01% 543
2019
Q4
$791K Buy
10,170
+420
+4% +$32.7K 0.01% 552
2019
Q3
$715K Sell
9,750
-300
-3% -$22K 0.01% 560
2019
Q2
$619K Buy
10,050
+252
+3% +$15.5K 0.01% 418
2019
Q1
$625K Buy
9,798
+600
+7% +$38.3K 0.01% 411
2018
Q4
$470K Hold
9,198
0.01% 402
2018
Q3
$533K Sell
9,198
-1,815
-16% -$105K ﹤0.01% 405
2018
Q2
$534K Sell
11,013
-1,950
-15% -$94.6K 0.01% 408
2018
Q1
$603K Sell
12,963
-2,850
-18% -$133K 0.01% 401
2017
Q4
$594K Buy
+15,813
New +$594K 0.01% 403
2016
Q3
Sell
-6,930
Closed -$231K 540
2016
Q2
$231K Hold
6,930
﹤0.01% 504
2016
Q1
$204K Buy
+6,930
New +$204K ﹤0.01% 516